SCHEMBL1333769

SCHEMBL1333769

C[CH]C(C)c1ncccc1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
MMP2 P08253 1/20 0.38
CHRM1 P11229 1/20 0.38
TSHR P16473 1/20 0.38
COMT P21964 1/20 0.38
ADRA1A P35348 1/20 0.38
METAP2 P50579 1/20 0.38
METAP1 P53582 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB2 P47870 1/20 0.38
IDO1 P14902 2/20 0.36
KDM4E B2RXH2 6/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 2/20 0.34
SLC6A2 P23975 1/20 0.34
KMT2A Q03164 2/20 0.34
ALOX12 P18054 1/20 0.33
PDK2 Q15119 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30853079 0.82 ALDH1A1 (0.42) ALDH1A1L3MBTL1MMP2CHRM1TSHR
SCHEMBL364693 0.81 GABRA1 (0.50) ALDH1A1L3MBTL1MMP2CHRM1TSHR
SCHEMBL31155959 0.81 GABRA1 (0.50) ALDH1A1L3MBTL1MMP2CHRM1TSHR
Methane SCHEMBL10700573 0.79 GABRA1 (0.48) ALDH1A1L3MBTL1MMP2CHRM1TSHR
SCHEMBL1332412 0.78 NOS3 (0.42) L3MBTL1CHRM1METAP2KDM4ENPC1
SCHEMBL1331957 0.77 HDAC8 (0.31) ALDH1A1HDAC8KDM4EHPGDHTT
SCHEMBL1333758 0.77 CYP2D6 (0.36) ALDH1A1L3MBTL1CHRM1KDM4EPDK2
SCHEMBL1331936 0.77 TRPM8 (0.36) ALDH1A1KDM4EHTTKMT2APDK2
SCHEMBL1333036 0.77 CYP2D6 (0.36) ALDH1A1CYP2C19
SCHEMBL18361548 0.76 ALDH1A1 (0.41) ALDH1A1L3MBTL1MMP2CHRM1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281885-A1 THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN PURDUE PHARMA L.P. (US) 2011-11-17 US disclosed
US-7799786-B2 Therapeutic agents useful for treating pain PURDUE PHARMA L.P. (US) 2010-09-21 US disclosed
US-20080153835-A1 Therapeutic agents useful for treating pain EURO-CELTIQUE S.A. 2008-06-26 US disclosed
EP-1556354-B1 THERAPEUTIC PIPERAZINE DERIVATES USEFUL FOR TREATING PAIN EURO CELTIQUE SA (LU) 2008-01-23 EP disclosed
US-7279493-B2 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell EURO-CELTIQUE S.A. 2007-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153835-A1 Therapeutic agents useful for treating pain CHRM2, CHRM1, MC1R ALDH1A1 1472/4885L3MBTL1 1012/4885MMP2 1566/4885
US-20110281885-A1 THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN CHRM2, CHRM1, MC1R ALDH1A1 1472/4885L3MBTL1 1012/4885MMP2 1566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.